Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NasalGuard, a brand of Trutek Corp., is a healthcare company specializing in preventative respiratory health through its proprietary electrostatic technology. The company's flagship product is a topical gel that, when applied around the nostrils, creates an invisible electrostatic field to trap and block airborne allergens, pollutants, and viruses. This drug-free and non-invasive solution is designed to prevent respiratory issues such as hay fever, asthma, and viral infections before they start. NasalGuard's technology has been clinically tested and is marketed globally as a safe alternative for all ages, including children and pregnant women. The company continues to focus on expanding its reach in the consumer health market by providing innovative, non-pharmacological protection against environmental triggers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NasalGuard.